Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 24, 2018

SELL
$166.05 - $186.51 $974,713 - $1.09 Million
-5,870 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $994,554 - $1.16 Million
5,870 New
5,870 $1 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $458,602 - $512,399
-2,717 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $395,138 - $451,142
-2,362 Reduced 46.51%
2,717 $507,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,079
5,079 $875,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Perella Weinberg Partners Capital Management LP Portfolio

Follow Perella Weinberg Partners Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perella Weinberg Partners Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Perella Weinberg Partners Capital Management LP with notifications on news.